⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,714.66
+0.31%
Nasdaq 100
29,538.44
+0.03%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.67
−0.19%
NYSE:TSM
$426.49
+1.49%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,121.27
−0.47%
Brent
$109.18
−0.03%
BTC
$82,435.27
+0.72%
ETH
$2,432.08
+1.12%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,714.66
+0.31%
Nasdaq 100
29,538.44
+0.03%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.67
−0.19%
NYSE:TSM
$426.49
+1.49%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,121.27
−0.47%
Brent
$109.18
−0.03%
BTC
$82,435.27
+0.72%
ETH
$2,432.08
+1.12%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Moderna Inc · News · TradingHolo
Markets
›
United States
› NAS
› MRNA
M
Moderna Inc
NAS:MRNA
Healthcare
CBOE:SPESG
NASDAQ:NBI
$240.94
+6.19%
Live
In session · ≈
AED 884.85
· Market cap
$96.19B
· Next earnings
Thu 5 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
MRNA news
Headlines tagged to this company
BE
Moderna's Cancer Vaccine Win Is Merck's Story Too
Benzinga · 62 d ago
FO
Moderna Co-Founder Robert Langer Is A Billionaire Again As Shares Double In Value
Forbes · 62 d ago
FX
S&P500: Treasury Buyback Lifts US Stocks as Moderna Cancer Data Sparks Rally
FXEmpire · 62 d ago
BL
Merck, Moderna Stocks Soar After Melanoma Trial Success
Bloomberg Markets and Finance · 62 d ago
CN
Market Open: Stocks Mixed, Bond Yields Fall On Treasury Action, Moderna Shares Pop 8/19/26
CNBC Television · 62 d ago
BU
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma
Business Wire · 63 d ago
ZA
Moderna Q2 Earnings Call Highlights Cost Cuts and Pipeline Milestones
Zacks Investment Research · 74 d ago
FA
This new kind of flu shot by Moderna has just been approved by the FDA
Fast Company · 75 d ago
FO
Moderna Stock Flashing Intriguing ‘Buy The Dip' Signal
Forbes · 75 d ago
BE
Beyond COVID: Moderna Wins FDA Approval for Its Seasonal Flu Vaccine
Benzinga · 75 d ago
SC
Moderna Stock Climbs on Flu Vaccine Approval
Schaeffers Research · 75 d ago
BA
Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future
Barrons · 75 d ago
FO
FDA Approves First mRNA Flu Vaccine For Older Adults
Forbes · 76 d ago
WS
The Food and Drug Administration approved Moderna's mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February.
WSJ · 76 d ago
RE
US FDA approves first mRNA flu shot from Moderna
Reuters · 76 d ago
AC
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
Accesswire · 76 d ago
AC
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Accesswire · 77 d ago
AC
Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
Accesswire · 82 d ago
← Previous
End of the feed